pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Nicorette
drug
save

nicotine

Marketedupdated 5mo ago
by NAL Pharmaceuticals Ltd
Approved
community read0 votes

🐶 often sniffed alongside

top 5
  • drugnicotine ER11 co-mentions · 11 sources
  • tagApproval8 co-mentions · 4 sources
  • drugnicotine polacrilex4 co-mentions · 4 sources
  • companyWake Forest University1 co-mentions · 1 sources
  • companyPacific Dental College and Hospital1 co-mentions · 1 sources

all catalysts(1)

phase 2 3 initiation · 1
Apr 29, 2026
phase 2 3 initiation
5mo ago
Pacific Dental College and Hospital — nicotine (Phase II/III Trial Initiation)
nicotine
→

Trials studying nicotine

  • EP1Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Canceractive not recruitingn=630
  • N/AExploratory Randomized, Controlled, Dose-response Study on the Impact of Nicotine From Five Variants of a Nicotine Tablet (NICOTINE TABLET) on Attentionactive not recruitingn=40
  • phase4Reward Sensitivity and Pharmacotherapy for Smoking Cessationactive not recruitingn=204
  • phase3Adaptive Use of Nicotine Substitution to Maintain Smoking Reduction/Abstinence in Nicotine Responderscompletedn=150
  • phase4C-Raven, a Virtual Tobacco Cessation Intervention in the Communitycompletedn=10
  • N/AA Bioavailability Study of Nicotine Delivered by an Electronic Vapour Productcompletedn=12
  • N/ACSD231005 Nicotine Pouch Biomarkers of Exposurecompletedn=200
  • phase3Evaluate Harm Reduction Products as a Second Line Intervention for Adult Smokers Who Do Not Quit With NRTterminatedn=4

Patent cliff

source: FDA Orange Book
first barrier falls
Apr 30, 2028
~1.6 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (6)

  • Jun 14, 2029formulationUS 85011642.7y
  • Jun 14, 2029formulationUS 85011642.7y
  • Apr 30, 2029formulationUS 89407722.6y
  • Apr 30, 2029formulationUS 89407722.6y
  • Apr 30, 2028formulationUS 83236831.6y
  • Apr 30, 2028patentUS 83236831.6y

News(10)

  • Opinion: 3 lessons from the tobacco settlement on how states should use money from Meta
    “Whether it’s nicotine or algorithms, the result is the same: reinforcing a behavior that is harmful to users,” writes Susan Morrisey.
    stat · 18d ago
  • An administrative gap delays access to new pancreatic cancer treatment
    A new wave of illegal fruity vapes, more and more kids on GLP-1s, and other health news from Morning Rounds
    stat · 25d ago
  • Reynolds is selling fruity new vapes unauthorized by FDA
    The decision to move ahead with new products in the absence of FDA authorization could spur other big manufacturers to do the same, one tobacco-nicotine expert said.
    stat · 25d ago
  • Juul gets OK to sell updated vaping device with age-gating technology
    Juul has received FDA clearance to sell an updated version of its e-cigarette, which includes an optional age-verification system designed to prevent underage use.
    stat · 1mo ago
  • Vaping and cannabis hit record highs among young adults in 2025: Survey
    Young adults’ use of vapes and cannabis hit all-time highs last year, according to a new survey.
    stat · 1mo ago
  • Anthony Fauci’s pandemic-era diary entries
    New data on American substance use, concerns of a global HIV resurgence, and more health news from Morning Rounds
    stat · 2mo ago
  • Quitting smoking is hard. A Medicare change may push doctors to give more help
    Physicians who offer counseling on quitting cigarettes and alcohol during patient visits would get a 19% increase in reimbursement under a proposed Medicare change.
    stat · 2mo ago
  • Flood of comments on White House grantmaking overhaul is largely negative, analysis shows
    An analysis of public comments on a White House proposal to change the way federal contracts and grants are doled out shows widespread opposition
    stat · 2mo ago
  • Majority of new Ebola cases in eastern Congo are from unknown chains, as outbreak outpaces response
    The Ebola outbreak in eastern Congo “continues to outpace the response efforts,” the WHO’s emergencies chief said on Tuesday after returning from a trip to one of the worst hit…
    stat · 2mo ago
  • The risk of refusing a newborn’s vitamin K shot
    Health care workers on strike at Ebola treatment center, how to tackle the U.S. alcohol epidemic, and more Morning Rounds news
    stat · 2mo ago
view all news mentions →
brand
Nicorette
generic
nicotine [USP]
indication
Smoking Cessation
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 50m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?